Cardinal Health Q4 Results: EPS Expected At $2.42, Revenue Hits $65.1 Billion
Cardinal Health (NYSE: CAH) is set to report Q4 earnings Aug. 11. Analysts expect EPS of $2.42 versus $2.08 a year earlier and revenue of $65.11 billion versus $60.16 billion. The company also announced acquisitions: buying Adapthealth’s diabetes business and Strive Medical for $360 million cash. CAH shares closed Monday at $237.18.
How this was made
The 30-second read
Why it matters
The combination of an earnings print with explicit consensus numbers and a disclosed acquisition price sets up a near-term repricing window, especially around profitability quality and cash-flow effects.
Market read
Consensus EPS and revenue expectations plus a specific acquisition spend create a clear catalyst for volatility and positioning ahead of the print.
What to watch
Traders may focus less on consensus topline and more on free cash flow impact, acquisition-related costs, and any commentary on funding/liquidity not detailed in the article.
Background
Cardinal Health is scheduled to release Q4 earnings and recently announced a $360M cash acquisition related to diabetes health.
Ticker impact
Cardinal Health reports Q4 before the open Aug 11, with consensus EPS $2.42 and revenue $65.11B, plus a $360M diabetes acquisition.
Likely elevated volatility into the open; direction depends on whether EPS/revenue beat and whether acquisition funding pressures free cash flow.
The article provides explicit consensus targets and a specific cash deal size, but no actual results or guidance changes yet, so the post-print move is conditional.
Market effects
Could influence sentiment for healthcare distribution and specialty pharmacy peers via read-through on margins and chronic-care demand.
Limited direct regional impact; primarily US healthcare services sentiment.
Low global spillover beyond US healthcare services, unless acquisition signals broader specialty expansion.
Counterpoint
Even with revenue and EPS growth expectations, the market may discount the acquisition if it is seen as cash-flow dilutive or integration-risky.
Key entities
- companyCardinal Health Inc
US healthcare services/distribution company reporting Q4 earnings Aug 11 and planning a $360M cash acquisition.
- companyAdapthealth
Seller of the diabetes health business Cardinal Health plans to acquire (per article).
- companyStrive Medical
Seller of the diabetes health business Cardinal Health plans to acquire (per article).
